Marketa Janatova

Prague, PR, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 62 publications

Current evidence and knowledge gaps on remote monitoring in people with multiple sclerosis - a systematic scoping review.

Current evidence and knowledge gaps on remote monitoring in people with multiple sclerosis - a systematic scoping review.

Journal: Disability and rehabilitation. Assistive technology

Published: June 25, 2026

Reporting framework in the testing of predisposition to common adult solid tumors using next-generation sequencing.

Reporting framework in the testing of predisposition to common adult solid tumors using next-generation sequencing.

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti

Published: May 25, 2026

Short-Term Lymphocyte Culture Improves the Diagnostic Yield of Targeted RNA NGS in Cancer Predisposition Testing.

Short-Term Lymphocyte Culture Improves the Diagnostic Yield of Targeted RNA NGS in Cancer Predisposition Testing.

Journal: Folia biologica

Published: April 14, 2026

Ovarian cancer and multimodal prehabilitation options - a case study.

Ovarian cancer and multimodal prehabilitation options - a case study.

Journal: Ceska gynekologie

Published: March 17, 2026

Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer.

Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer.

Journal: Breast (Edinburgh, Scotland)

Published: July 09, 2025

Semi-automated RNA Isolation from Tempus Blood RNA Tubes Using the Magcore Plus II Instrument.

Semi-automated RNA Isolation from Tempus Blood RNA Tubes Using the Magcore Plus II Instrument.

Journal: Folia biologica

Published: July 08, 2025

Development and Technical Validation of the Clinical Lymphoma Exploration and Research Sequencing (CLEARS) Panel and Its Optimization for ctDNA Analysis.

Development and Technical Validation of the Clinical Lymphoma Exploration and Research Sequencing (CLEARS) Panel and Its Optimization for ctDNA Analysis.

Journal: Folia biologica

Published: January 01, 2025

The guidelines for clinical practice for carriers of germline mutations in the Lynch syndrome predisposition genes MLH1, MSH2, MSH6, PMS2 and large deletions of EPCAM (4.2024).

The guidelines for clinical practice for carriers of germline mutations in the Lynch syndrome predisposition genes MLH1, MSH2, MSH6, PMS2 and large deletions of EPCAM (4.2024).

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti

Published: November 08, 2024

The guidelines for clinical practice for carriers of germline mutations in hereditary breast, ovarian, prostate, and pancreatic cancer predisposition genes BRCA1, BRCA2, PALB2, ATM, and CHEK2 (4.2024).

The guidelines for clinical practice for carriers of germline mutations in hereditary breast, ovarian, prostate, and pancreatic cancer predisposition genes BRCA1, BRCA2, PALB2, ATM, and CHEK2 (4.2024).

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti

Published: August 22, 2024

Parallel DNA/RNA NGS Using an Identical Target Enrichment Panel in the Analysis of Hereditary Cancer Predisposition.

Parallel DNA/RNA NGS Using an Identical Target Enrichment Panel in the Analysis of Hereditary Cancer Predisposition.

Journal: Folia biologica

Published: June 03, 2024

RAD51 recruitment but not replication fork stability associates with PARP inhibitor response in ovarian cancer patient-derived xenograft models.

RAD51 recruitment but not replication fork stability associates with PARP inhibitor response in ovarian cancer patient-derived xenograft models.

Journal: NAR cancer

Published: May 21, 2024

Site-saturation functional screens identify PALB2 missense variants associated with increased breast cancer risk.

Site-saturation functional screens identify PALB2 missense variants associated with increased breast cancer risk.

Journal: Nature communications

Published: April 07, 2024

Showing 1-12 of 62

Last Updated: 09/26/2026